Skip to content

Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy

Comparison of Aerobic Versus Resistance Exercise Training in Enhancing Quality of Life in Early Stage Breast Cancer Survivors Receiving Chemotherapy: A Multi-Centre Randomized Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00115713
Enrollment
240
Registered
2005-06-24
Start date
2003-04-30
Completion date
2005-12-31
Last updated
2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Keywords

Aerobic Exercise, Weight Lifting, Breast Cancer, Quality of Life

Brief summary

The purpose of this study is to compare the effects of two different types of exercise, aerobic exercise training (AET) and resistance exercise training (RET), on quality of life (QoL) in early stage breast cancer survivors receiving chemotherapy. It is hypothesized that both AET and RET would have beneficial effects on QoL.

Detailed description

The study was a prospective, three-armed, randomized controlled trial. Participants were stratified by site (Edmonton, Ottawa, and Vancouver) and planned chemotherapy protocol (taxane-based versus nontaxane-based) and randomly assigned to AET, RET, or usual care (UC) in a 1:1:1 ratio using a random-numbers table. Participants assigned to the AET group were asked to perform aerobic exercise three times per week on a recumbent or upright cycle ergometer, treadmill, or elliptical. Exercise duration began at 15 minutes for weeks 0 through 2, and then systematically increased by 5 minutes every three weeks thereafter to 45 minutes for weeks 18 and beyond. Exercise intensity began at 60% of VO2max for weeks 0 through 2 and then systematically increased by 10% every 6 weeks thereafter to 80% of VO2max for weeks 12 and beyond. Warm-up and cool-down periods consisted of 5 minutes of aerobic activity at the power output of the ventilatory equivalent for oxygen (approximately 50% of peak oxygen consumption). Participants assigned to the RET group were asked to perform resistance exercise three times per week, which consisted of two sets of 10 repetitions of 9 different exercises performed at 60-70% of 1-repetition maximum. The specific exercises were: leg extension, leg curl, calf raises, chest press, latissimus pulldown, overhead press, triceps extension, biceps curls, and modified curl-ups. Resistance was increased by approximately 10% or the next weight level when the participant was able to complete 12 repetitions per set without difficulty.

Interventions

BEHAVIORALAerobic Exercise Training
BEHAVIORALResistance Exercise Training

Sponsors

Canadian Breast Cancer Research Alliance
CollaboratorOTHER
University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Breast cancer early stage I -IIIA * Completed axillary surgery * Scheduled to receive adjuvant chemotherapy for 9 - 24 weeks * Approval of the treating oncologist * Able to understand and provide written informed consent in English or French (Ottawa) * 18+ years of age * No uncontrolled hypertension, cardiac illness, psychiatric condition * No contraindication to exercise as determined by a fitness test

Exclusion criteria

* Pregnant. * Unwilling to accept randomization. * Any medical condition that would be a contraindication to exercise. The clinicians will make this decision. * Unwilling to travel to/participate in the exercise program as defined by the protocol. * Previous chemotherapy (previous cancer is NOT an

Design outcomes

Primary

MeasureTime frame
Quality of Life

Secondary

MeasureTime frame
Body Composition
Lymphedema
Physical Fitness
Selected Biomarkers
Exercise Adherence Rates and Determinants
Treatment Completion Rates

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026